Baxter International Inc. closed 25.71% short of its 52-week high of $44.01, which the company reached on March 8th.

I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.

Baxter International Inc. closed 23.96% short of its 52-week high of $44.01, which the company reached on March 8th.

Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, is a healthcare leader committed to transforming lives ...

Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...

But now the factory is almost fully restored to pre-hurricane production levels. "We continue to make strong progress at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

I’m talking about Zacks Rank #5 (Strong Sell) Baxter ( BAX ).Baxter International Inc., through its subsidiaries, develops ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time ...